6/3/26 21:04 | 6/1/26 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | | D | | M.d | 0 | 0.00 | 0 | 3 | 29 | 12 | D | | | | | | | | | | | | | | |
5/13/26 21:40 | 5/12/26 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | | D | | M.d | 26 | 7.38 | 0 | 4 | 49 | 11 | D | | | | | | | | | | | | | | |
6/6/25 17:58 | 6/5/25 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | | S.d | 0 | 30.48 | 0 | 0 | 0 | 7 | D | | | | | | | | | | | | | | |
5/16/25 17:59 | 5/14/25 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | | M.d | 65 | 12.57 | 0 | 5 | 257 | 7 | D | | | | | | | | | | | | | | |
3/8/24 17:28 | 3/7/24 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | | S | -602 | 46.28 | 0 | -13 | -87 | 2 | D | | | | | | | | | | | | | | |
8/11/22 16:19 | 8/11/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | | P | 90 | 2.03 | 0 | 44 | 370 | 56 | D | | | | | | | | | | | | | | |
8/23/21 18:28 | 8/23/21 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | | P | 23 | 7.99 | 0 | 3 | 31 | 12 | D | | | | | | | | | | | | | | |
8/20/21 16:10 | 8/18/21 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | | P.m | 26 | 8.05 | 0 | 3 | 53 | 9 | D | | | | | | | | | | | | | | |
8/17/21 16:05 | 8/16/21 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | | P | 49 | 8.10 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |
8/14/17 18:05 | 8/11/17 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | | P | 42 | 2.82 | 0 | 15 | New | 15 | D | | | | | | | | | | | | | | |